SPARC-1613
N/A
Report date: 2023/10/04 20:07:40
NME
Base Information
Drug NameSPARC-1613
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSun Pharma Advanced Research Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesSun Pharma Advanced Research Company Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A